Pharma News

EMA has published public consultation its updated scientific advice on the categorisation of antimicrobials . The scientific advice refines the classification of these medicines according to the risk their use in animals causes to public health through the possible development of antimicrobial resistance.

As per information of the Botanical Survey of India (BSI), an organization under Ministry of Environment, Forests & Climate Change estimated more than 8,000 species of medicinal plants are found in India.

Researchers have found that treating psoriasis, a chronic inflammatory skin disease, with biologic drugs that target immune system activity can reduce the early plaque buildup that clogs arteries, restricts blood flow, and leads to heart attacks and stroke. The findings highlight how immunotherapies that treat inflammatory conditions might play a role in the reduction of cardiovascular disease risks. The study, funded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, appears online today in the journal Cardiovascular Research.

The Ministry of AYUSH is organising State AYUSH and Health Ministers Conference on 6-2-2019  at New Delhi. The AYUSH /Health Ministers along with senior Officers from all the State and UT Government have been invited to participate in deliberation related to issues concerning AYUSH Sector. 

The U.S. Food and Drug Administration is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage. Medical product distributor Terrific Care/Medex Supply LLC issued a voluntary recall of certain Roche Diagnostics test strip lots used with CoaguChek test meter devices last month. The FDA classified this action as a Class I recall, the most serious type of recall, which means use of these devices may cause serious injuries or death. This recall is related to the November 2018 Roche Diagnostics Recall, the manufacturer of CoaguChek meters and test strips.

Companies that make sartan blood pressure medicines (also known as angiotensin II receptor blockers) are being required to review their manufacturing processes so that they do not produce nitrosamine impurities.

EMA’s human medicines committee (CHMP) recommended six medicines for approval at its January 2019 meeting.

The CHMP adopted a positive opinion for Ajovy (fremanezumab), for the prophylaxis of migraine.

EMA’s human medicines committee (CHMP) has recommended for the first time an adjunct treatment to insulin in the form of a tablet for certain patients with type 1 diabetes mellitus.

[adsense:336x280:8701650588]

EMA, the Heads of Medicines Agencies (HMA) and the European Commission (EC) are launching  six-month public consultation on draft key principles which will form the basis on which the electronic product information (ePI) for human medicines will be developed and used in the European Union.